HIGHLIGHTS
- who: Ana Martinez-Naharro from the National Centre, Division of Medicine, University College London, Royal Free Hospital, London, UK have published the research: Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment, in the Journal: (JOURNAL)
- what: The aim of this study was to assess the ability of CMR with ECV mapping to (i) measure changes in response to chemotherapy, (ii) asu00ad sess the correlation between haematological response and changes in ECV, and_(iii) assess the association between changes in ECV and prognosis over and above existing predictors. In this prospective study, the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.